Cross Country Healthcare Confirms Acquisition by Knox Lane Amidst Significant Q1 Revenue Decline and Widening Losses

summarizeSummary

Cross Country Healthcare's Q1 2026 results show a sharp revenue decline and increased losses, providing context for the previously announced definitive merger agreement with Knox Lane for $13.25 per share.

check_boxKey Events

• Definitive Merger Confirmed

  The company reaffirmed its definitive agreement to be acquired by Knox Lane for $13.25 per share, a transaction that will result in the company's delisting.

• Significant Q1 Revenue Decline

  Revenue for the first quarter of 2026 decreased by 17.8% year-over-year to $241.1 million, primarily due to volume declines in both Nurse and Allied Staffing and Physician Staffing segments.

• Widening Net Loss

  The company reported a net loss of $4.3 million for Q1 2026, a substantial increase from a net loss of $0.5 million in the prior-year period.

• Increased Operating Losses

  Loss from operations worsened to $4.155 million in Q1 2026, compared to $0.977 million in Q1 2025.

auto_awesomeAnalysis

This 10-Q filing confirms the definitive merger agreement with Knox Lane for $13.25 per share, a transaction previously announced on May 6, 2026. The filing also reveals a substantial deterioration in Q1 2026 financial performance, with revenue decreasing by 17.8% year-over-year to $241.1 million and net loss widening significantly from $0.5 million to $4.3 million. These poor results provide a clear fundamental backdrop for the company's decision to accept the acquisition offer, offering shareholders an exit at a premium to the current market price despite the challenging operational environment. The merger is expected to lead to the company's delisting from Nasdaq.